Copy Link Print Information

Activin A Protein, Human/Mouse/Rat (HEK293)

24 Cited Publications
Customer Review

Based on 24 publication(s) in Google Scholar

Activin A, a multifunctional cytokine, is a member of TGF-β superfamily. Activin A first binds to the type II activin receptors (ActIIRA or ActRIIB) on the member surface, and then recruits and phosphorylates type I activin receptors (ActRI). Activin A primarily signal through SMAD2/3 proteins to regulate a variety of functions, including inflammation, fibrosis, and tumorigenesis. Activin A Protein, Human/Mouse/Rat (HEK293) is produced in HEK293 cells, and consists of 117 amino acids (G310-S426).

For research use only. We do not sell to patients.
  • Species: Rat; Mouse; Human
  • Source: HEK293
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Activin A Protein, Human/Mouse/Rat (HEK293) Product Image
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Service
Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Biological Activity

Description

Activin A, a multifunctional cytokine, is a member of TGF-β superfamily. Activin A first binds to the type II activin receptors (ActIIRA or ActRIIB) on the member surface, and then recruits and phosphorylates type I activin receptors (ActRI). Activin A primarily signal through SMAD2/3 proteins to regulate a variety of functions, including inflammation, fibrosis, and tumorigenesis[1]. Activin A Protein, Human/Mouse/Rat (HEK293) is produced in HEK293 cells, and consists of 117 amino acids (G310-S426).

Background

Activin is a member of transforming growth factor-β (TGF-β) superfamily consisting of two inhibin β subunits linked by disulfide bonds. Activin A is expressed widely in various tissues and cells with strong bioactivities and is the mostly studied activin[1].
The sequence of amino acids in Activin A proteins from different species is very stable, which leads to the conclusion that in the process of evolution, Activin A has been only slightly altered, and that both in humans and in animals, its function is similar.
Activin exists in three basic molecular forms composed of two inhibin β subunits: activin A (βAβA), activin B (βBβB), and activin AB (βAβB). Activin A binds with high affinity to activin type II receptors, which recruit type I receptors and are necessary for the activation of Smad2/3 signaling. The phosphorylated ActRI activates Smad2 and Smad3, which form a complex with Smad4 to translocate to the nucleus. Activin and TGF-β share the same signaling pathway at the level of Smad2/3/4. Activin A exerts a variety of biological functions including regulation of hematopoietic cell proliferation, neuron differentiation, pituitary hormone secretion, and tissue repair. It is also involved in the process of many diseases, for example, inflammation, fibrosis and tumorigenesis[1][2].
Activin A has pro- and anti-tumorigenic functions depending on the tumor type. In breast, liver and colon cancers, activin signals were revealed to inhibit tumor cell growth. In addition, tumor tissues were revealed to express decreased levels of activin A or increased levels of activin antagonists or demonstrated the downregulation of activin receptors or Smad proteins. Moreover, its roles include embryonic differentiation, trophoblast invasion of the uterine wall in early pregnancy, and fetal/neonate brain protection in hypoxic conditions. Activin A also regulates bone formation and regeneration, enhances joint inflammation in rheumatoid arthritis, and triggers pathogenic mechanisms in the respiratory system[1][2].

In Vitro

Recombinant Activin A (0-10 ng/mL; for 12 and 24 h) inhibits the proliferation of myeloma cell line NS-1 cells and induces NS-1 cell apoptosis. Activin A upregulates the expression of CHOP, GADD34, caspase-3, and caspase-12. Moreover, both Smad3 and p-Smad3 levels are increased with treatment of activin A in NS-1 cells[1].
Recombinant Activin A (1, 5, 50, 100, 200 ng/mL) increases the abundance of specific globin probe fragments for gamma and epsilon globins (209 nucleotides) as well as alpha (180 nucleotides), which are protected from S1 digestion, in the human erythroid cell line, K562[3].
Recombinant Activin A (50 ng/mL; 6-72 hours) increases the cell content of FSH and total FSH (secreted plus intracellular) in rat pituitary cells[5].

In Vivo

Recombinant Activin A (20 ng/1 µL; intratumoral injection; for 6 days) inhibits the growth of solid tumors in tumor-bearing mice with NS-1 cells[1].
Recombinant Activin A (1 μg/20 μL; i.c.v.; once) reduces the neuronal loss in the hippocampal CA1/2 region, dorsolateral striatum but not in the parietal cortex in a 15-min hypoxic-ischemic (HI) injury in the rat brain. Activin A can enhance the survival of injured hippocampal and striatal neurons[4].

Verified Bioactivity

1. The ED50 for this effect is <8 ng/mL, as measured by its ability to inhibit proliferation of MPC-11 cells.
2. The ED50 is less than 8 ng/mL, as measured by its ability to induce SMAD signaling in 293-Activin A Res cells.
3.Measured by its binding ability in a functional ELISA. Immobilized Human/ Mouse/Rat Activin A at 5 μg/mL (100 μL/well) can bind Biotinylated Human Activin RIIB(HY-P7456), The ED50 for this effect is 28.27 ng/mL.
4.Measured by its binding ability in a functional ELISA. Immobilized Human /Mouse/Rat Activin A at 5 μg/mL (100μL/well) can bind ACVR2A(HY-P75537), The ED50 for this effect is 19.1 ng/mL.

MCE Validation Data

  • Purity - SDS-PAGE

    Purity - SDS-PAGE

    ≥ 95%, as determined by reducing SDS-PAGE.

  • Bioactivity - ELISA

    Bioactivity - ELISA

    Immobilized Activin A Protein, Human/Mouse/Rat can bind Cibotercept (HY-P990733). The EC50 for this effect is 32.97 ng/mL.

  • Bioactivity - Cell-Based Assay

    Bioactivity - Cell-Based Assay

    Measured by its ability to inhibition on MPC11 cell proliferation. The ED50 for this effect is typically 0.7508 ng/mL, corresponding to a specific activity is 1.33×106 units/mg.

  • Bioactivity - ELISA

    Bioactivity - ELISA

    Measured by its binding ability in a functional ELISA. Immobilized Human/ Mouse/Rat Activin A at 5 μg/mL (100 μL/well) can bind Biotinylated Human Activin RIIB (HY-P7456), The ED50 for this effect is 28.27 ng/mL.

  • Bioactivity - ELISA

    Bioactivity - ELISA

    Measured by its binding ability in a functional ELISA. Immobilized Human /Mouse/Rat Activin A at 5 μg/mL (100μL/well) can bind ACVR2A (HY-P75537), The ED50 for this effect is 19.1 ng/mL.

Technical Parameters

  • Species Rat; Mouse; Human
  • Source HEK293
  • Tag Tag Free
  • Accession

    P08476 (G311-S426)

  • Gene ID
    3624  [NCBI]
  • Molecular Construction
    • N-term
    • Activin A (G311-S426)
      Accession # P08476
    • C-term
  • Protein Length

    Full Length of Mature Protein

  • Synonyms

    Interleukin-18 receptor 1; IL-18R1; CDw218a; IL1RRP; IL-18R-alpha; CD218a

  • AA Sequence

    GLECDGKVNICCKKQFFVSFKDIGWNDWIIAPSGYHANYCEGECPSHIAGTSGSSLSFHSTVINHYRMRGHSPFANLKSCCVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS

  • Predicted Molecular Mass

    13 kDa

  • Molecular Weight

    Approximately 14-15 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.

  • Purity

    ≥ 95%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Lyophilized powder.

Formulation

1.Lyophilized from a 0.22 μm filtered solution of 4 mM HCl, 4% mannitol, pH 2.5.
2.Lyophilized from a 0.22 μm filtered solution of 4 mM HCl, pH 0.8.
3.Lyophilized from a 0.22 μm filtered solution of 4 mM HCl, pH 2.5.
Please refer to the lot-specific COA for specific buffer information.

Endotoxin Level

<0.01 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

References

[1]. Ge J, et al. Involvement of CHOP in activin A induced myeloma NS 1 cell apoptosis. Oncol Rep. 2019;42(6):2644-2654. [Content Brief]

[2]. Enrrico Bloise, et al. Activin A in Mammalian Physiology. Physiol Rev. 2019 Jan 1;99(1):739-780. [Content Brief]

[3]. N L Frigon Jr, et al. Regulation of globin gene expression in human K562 cells by recombinant activin A. Blood. 1992 Feb 1;79(3):765-72. [Content Brief]

[4]. D D Wu, et al. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res. 1999 Jul 24;835(2):369-78. [Content Brief]

[5]. B Attardi, et al. Rapid stimulatory effect of activin-A on messenger RNA encoding the follicle-stimulating hormone beta-subunit in rat pituitary cell cultures. Mol Endocrinol. 1990 May;4(5):721-6. [Content Brief]

View More

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00

Measured by its ability to inhibit anti-CD3-induced proliferation of stimulated CTLL-2 mouse cytotoxic T cells. The ED50 this effect is 0.8023 μg/ml, corresponding to a specific activity is 1246.42 units/mg.

Assay Types
  • 1/16

    MedChemExpress Validation
     ≥ 95%, as determined by reducing SDS-PAGE.

  • 1/16

    MedChemExpress Validation
     Immobilized Activin A Protein, Human/Mouse/Rat can bind Cibotercept (HY-P990733). The EC50 for this effect is 32.97 ng/mL.

  • 1/16

    MedChemExpress Validation
     Measured by its ability to inhibition on MPC11 cell proliferation. The ED50 for this effect is typically 0.7508 ng/mL, corresponding to a specific activity is 1.33×106 units/mg.

  • 1/16

    MedChemExpress Validation
     Measured by its binding ability in a functional ELISA. Immobilized Human/ Mouse/Rat Activin A at 5 μg/mL (100 μL/well) can bind Biotinylated Human Activin RIIB (HY-P7456), The ED50 for this effect is 28.27 ng/mL.

  • 1/16

    MedChemExpress Validation
     Measured by its binding ability in a functional ELISA. Immobilized Human /Mouse/Rat Activin A at 5 μg/mL (100μL/well) can bind ACVR2A (HY-P75537), The ED50 for this effect is 19.1 ng/mL.

  • 1/16

    Activin A Protein, Human/Mouse/Rat (HEK293) purchased from MedChemExpress. Usage Cited in: Cell Regen. 2024 Sep 13;13(1):17. [Abstract]

    Customer Validation
     Cell morphology at different time points during myocardial differentiation from UiPSCs and hPSCs.All hPSC lines were induced to differentiate to definitive endoderm (DE) by treatment with 100 ng/ml Activin A (MCE, HY-P70311), 2.5 ng/ml human bFGF, 0.5 ng/ ml human BMP4 and 10 μM Y27632 for 3 days in SFD medium.

  • Activin A Protein, Human/Mouse/Rat (HEK293) Product Image
    1/16
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Experimental Validation Results for Activin A Protein, Human/Mouse/Rat (HEK293)
  • Activin A Protein, Human/Mouse/Rat (HEK293) Product Image

  • Activin A Protein, Human/Mouse/Rat (HEK293) purchased from MedChemExpress. Usage Cited in: Cell Regen. 2024 Sep 13;13(1):17. [Abstract]

    Cell morphology at different time points during myocardial differentiation from UiPSCs and hPSCs.All hPSC lines were induced to differentiate to definitive endoderm (DE) by treatment with 100 ng/ml Activin A (MCE, HY-P70311), 2.5 ng/ml human bFGF, 0.5 ng/ ml human BMP4 and 10 μM Y27632 for 3 days in SFD medium.